Clover Health Reports Director/Officer Changes & Financials
Ticker: CLOV · Form: 8-K · Filed: Apr 22, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Apr 22, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $525,000, $5,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, executive-changes
Related Tickers: CLOV
TL;DR
CLOV board shakeup & financials filed. Big changes ahead?
AI Summary
Clover Health Investments Corp. filed an 8-K on April 22, 2024, reporting changes in its board of directors and executive officers, as well as updates to compensatory arrangements. The filing also includes financial statements and exhibits, though specific details on these changes and financial performance are not provided in this summary.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy or governance, while financial statements provide insight into the company's performance and stability.
Risk Assessment
Risk Level: medium — Changes in leadership and the filing of financial statements can introduce uncertainty and reveal performance issues, impacting investor confidence.
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- April 22, 2024 (date) — Date of Report
FAQ
What specific changes were made to the board of directors or executive officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of disclosure, but the specific names and roles are not detailed in the provided text.
What are the key details of the updated compensatory arrangements for officers?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specific terms and amounts are not elaborated upon in the provided text.
What financial statements are included with this 8-K filing?
The filing states "Financial Statements and Exhibits" are included, but the specific statements (e.g., balance sheet, income statement) are not detailed in the provided text.
When was Clover Health Investments Corp. incorporated?
Clover Health Investments Corp. is incorporated in Delaware.
What is the principal executive office address for Clover Health?
The principal executive offices are located at 3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067.
Filing Stats: 1,233 words · 5 min read · ~4 pages · Grade level 11.4 · Accepted 2024-04-22 16:06:23
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
- $525,000 — s will receive an annual base salary of $525,000, and the initial target amount for his
- $5,000,000 — n Stock with a grant date fair value of $5,000,000, which will vest and become payable as
Filing Documents
- clov-20240422.htm (8-K) — 33KB
- exhibit991-cfoappointment.htm (EX-99.1) — 11KB
- 0001801170-24-000089.txt ( ) — 176KB
- clov-20240422.xsd (EX-101.SCH) — 2KB
- clov-20240422_lab.xml (EX-101.LAB) — 22KB
- clov-20240422_pre.xml (EX-101.PRE) — 13KB
- clov-20240422_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On April 22, 2024, the Company issued a press release announcing Mr. Kuipers' appointment. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated April 22, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: April 22, 2024 By: /s/ Terrence Ronan Name: Terrence Ronan Title: Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)